Tag: Neal Walker

Wayne-based Aclaris Therapeutics has entered into an exclusive licensing agreement with a Chinese biotechnology company worth up to $960 million, causing a spike in…

Pharma & Biotech

Chesterbrook's Aclaris Therapeutics Enters $31.5 Million Royalty, Milestone Payments Deal

July 23, 2024

Chesterbrook-based Aclaris Therapeutics has agreed to sell $31.5 million of its future Eli Lilly and Co. royalty and milestone payments to a Canadian…

Pharma & Biotech

Chesterbrook's Aclaris Therapeutics Parts Ways with CEO, Initiates Strategic Review Following Setbacks

January 30, 2024

Chesterbrook-based Aclaris Therapeutics has parted ways with its CEO and has started a strategic review after the recent setbacks with two of its new…

Commerce

Malvern’s Aclaris Buys Research Partner Confluence for Potential $100 Million

August 14, 2017

A joint research project over the past year has impressed dermatology-focused Aclaris Therapeutics enough to buy out St. Louis startup Confluence Life Sciences.

The…

Tag: Neal Walker

Wayne’s Aclaris Therapeutics Signs Exclusive Licensing Deal with Chinese Biotech

Chesterbrook's Aclaris Therapeutics Enters $31.5 Million Royalty, Milestone Payments Deal

Chesterbrook's Aclaris Therapeutics Parts Ways with CEO, Initiates Strategic Review Following Setbacks

Malvern’s Aclaris Buys Research Partner Confluence for Potential $100 Million